Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 82
- Reported
- 81
- Verified
- 75
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Proceed with caution
- Why
- Strong, vendor-documented performance numbers (SV recall 51.5%->87.8%, ~98% SNV phasing, $395/genome) and real early-access adoption (Broad Clinical Labs, GeneDx, Baylor), but short-read fundamentals, NovaSeq X lock-in, sample-quality sensitivity, and an incomplete TruPath<->ICM integration story warrant validation before reliance.
- Next
- Validate TruPath's SV recall and phasing on representative samples (meeting the 70% >10 kb / 40% >60 kb input guidance) against an established long-read baseline, and scope whether Connected Multiomics (research-only) meets the analysis use-case before building workflows on the 'connected' promise.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 0
- Tier 3
- 7
- Supports
- 4
- Contradicts
- 1
- Context
- 2
- Latest observed
- 2026-02-24
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.